Effects of sacubitril/valsartan versus irbesartan in patients with chronic kidney disease: a randomised double-blind trial

Effects of sacubitril/valsartan versus irbesartan in patients with chronic kidney disease: a randomised double-blind trial

<strong>Background</strong> Sacubitril/valsartan reduces the risk of cardiovascular mortality among patients with heart failure with reduced ejection fraction, but its effects on kidney function and cardiac biomarkers in people with moderate-to-severe chronic kidney disease are unknown....

Full description

Bibliographic Details
Main Authors:	Haynes, R, Judge, P, Staplin, N, Herrington, W, Storey, B, Bethel, A, Bowman, L, Brunskill, N, Cockwell, P, Hill, M, Kalra, P, McMurray, J, Taal, M, Wheeler, D, Landray, M, Baigent, C, UK HARP-III Collaborative Group
Format:	Journal article
Published:	American Heart Association 2018
Subjects:	Surgery Intervention Treatment Transplantation

Similar Items

Sacubitril/valsartan in peritoneal dialysis—lessons from a pharmacokinetic study
by: Judge, PK, et al.
Published: (2023)

Randomized multicentre pilot study of sacubitril/valsartan versus irbesartan in patients with chronic kidney disease: UK Heart and Renal Protection (UK HARP)-III. Rationale, trial design and baseline data
by: Haynes, R, et al.
Published: (2016)

Sacubitril/Valsartan for heart failure
by: Wenqin Dai, MM, et al.
Published: (2022-06-01)

Sacubitril/valsartan: A practical guide
by: Cândida Fonseca, et al.
Published: (2019-05-01)

Molecular mechanisms of sacubitril/valsartan in cardiac remodeling
by: Nor Hidayah Mustafa, et al.
Published: (2022-08-01)

Campath, calcineurin inhibitor reduction and chronic allograft nephropathy (the 3C Study) – results of a randomized controlled clinical trial
by: Haynes, R, et al.
Published: (2018)

Use of sacubitril/valsartan early after CABG
by: Madina Nurzhanova, et al.
Published: (2024-01-01)

Effects of Sacubitril/Valsartan on the Renal Resistance Index
by: Margherita Ilaria Gioia, et al.
Published: (2022-06-01)

Angioedema with concomitant use of sacubitril/valsartan and enalapril
by: Logamoorthy Ramamoorthy, et al.
Published: (2023-01-01)

Sacubitril/valsartan in real-life clinical practice
by: Yüksel Çavuşoğlu
Published: (2021-07-01)

Use of causal diagrams to inform the analysis and interpretation of observational studies: An example from the Study of Heart and Renal Protection (SHARP)
by: Staplin, N, et al.
Published: (2016)

Effects of Sacubitril/Valsartan on Serum Lipids in Heart Failure With Preserved Ejection Fraction
by: Senthil Selvaraj, et al.
Published: (2021-09-01)

Potential of valsartan+sacubitril therapy in hypertensive heart disease
by: A. G. Ovchinnikov, et al.
Published: (2021-08-01)

Potential mechanisms of beneficial effect of sacubitril/valsartan on glycemic control
by: Jelena P. Seferovic, et al.
Published: (2020-12-01)

Pathogenetic justification of sacubitril / valsartan use in respiratory-cardial comorbidity
by: T. V. Ashcheulova, et al.
Published: (2023-01-01)

Effects of sacubitril-valsartan in patients undergoing maintenance dialysis
by: Ying Ding, et al.
Published: (2023-12-01)

Sacubitril/Valsartan Ameliorates Crizotinib-Induced Cardiotoxicity in Mice
by: Lijun Cheng, et al.
Published: (2023-07-01)

The Diuretic Effect of Sacubitril/Valsartan Might Be Clinically Relevant
by: Luís Beck-da-Silva, et al.

Effectiveness of sacubitril–valsartan in cancer patients with heart failure
by: Ana Martín‐Garcia, et al.
Published: (2020-04-01)

Renin profiling predicts neurohormonal response to sacubitril/valsartan
by: Giuseppe Vergaro, et al.
Published: (2021-02-01)

Sacubitril/valsartan: evaluation of safety and efficacy as an antihypertensive treatment
by: Sarah L Anderson, et al.
Published: (2018-08-01)

Effects of sacubitril/valsartan in patients with cancer therapy-related heart failure
by: Marina V. Vitsenya, et al.
Published: (2023-09-01)

Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138 769 individuals The ARB Trialists Collaboration
by: Teo, K, et al.
Published: (2011)

Heart failure with preserved ejection fraction, red cell distribution width, and sacubitril/valsartan
by: Jawad H. Butt, et al.
Published: (2024-02-01)

Evidence for the prevention and treatment of stroke in dialysis patients
by: Herrington, W, et al.
Published: (2014)

Profile of sacubitril/valsartan in the treatment of heart failure: patient selection and perspectives
by: Yandrapalli S, et al.
Published: (2017-10-01)

Sacubitril/Valsartan in the Treatment of Resistant Hypertension: Raising Star or Illusion?
by: Marijana Tadic, et al.
Published: (2022-05-01)

The emerging role of sacubitril/valsartan in pulmonary hypertension with heart failure
by: Yu Xu, et al.
Published: (2023-05-01)

The efficacy and safety of Sacubitril/Valsartan on pulmonary hypertension in hemodialysis patients
by: Cong Zhao, et al.
Published: (2022-11-01)

The effects of sacubitril/valsartan and ramipril on the male fertility in hypertensive rats
by: Duygun Altıntaş Aykan, et al.
Published: (2020-10-01)

Sacubitril/valsartan in heart failure and end‐stage renal insufficiency
by: Alex Heyse, et al.
Published: (2019-12-01)

Sacubitril/valsartan in chronic kidney disease, the nephrologist point of view
by: Borja Quiroga, et al.
Published: (2019-11-01)

Eligibility for sacubitril–valsartan in patients with acute decompensated heart failure
by: David Carballo, et al.
Published: (2020-06-01)

Switching to sacubitril/valsartan or adding aldosterone antagonist: which first?
by: Carlos Escobar, et al.
Published: (2019-12-01)

Sacubitril/valsartan alleviates myocardial fibrosis in diabetic cardiomyopathy rats
by: Jiao Ai, et al.
Published: (2021-09-01)

A Rare Adverse Event of Rhabdomyolysis Caused by Sacubitril/Valsartan
by: Prashanth Rawla, et al.
Published: (2019-05-01)

Effect of processing delay and storage conditions on urine albumin-to-creatinine ratio
by: Herrington, W, et al.
Published: (2016)

Efficacy and safety of sacubitril/valsartan vs. valsartan in patients with acute myocardial infarction: A meta-analysis
by: Pei Yang, et al.
Published: (2022-08-01)

Conventional and genetic evidence on the association between adiposity and chronic kidney disease
by: Zhu, P, et al.
Published: (2020)

Experiencia con sacubitril/valsartán en una clínica de falla cardiaca
by: Maria P. Morales-Parra, et al.
Published: (2020-01-01)